2.7  0.06 (2.27%)		08-28 16:00
Open: 2.56 High: 2.7499 Volume: 40,946		Pre. Close: 2.64 Low: 2.55 Market Cap: 1,514(M)

Short term
Mid term
Targets	6-month :	3.58	1-year :	3.96
Resists	First :	3.06	Second :	3.39
Pivot price	2.68
Supports	First :	2.53	Second :	2.11
MAs	MA(5) :	2.65	MA(20) :	2.74
	MA(100) :	5.98	MA(250) :	8.47
MACD	MACD :	-0.3	Signal :	-0.4
%K %D	K(14,3) :	24.7	D(3) :	15.1
RSI	RSI(14): 41.6
52-week	High :	14.5	Low :	2.53

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ SLBT ] has closed below upper band by 45.0%. Bollinger Bands are 93.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 18 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	2.75 - 2.76	2.76 - 2.78
Low:	2.52 - 2.53	2.53 - 2.55
Close:	2.68 - 2.7	2.7 - 2.72

SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company’s products include SL bio’s milk-derived exosome essence, SL bio’s tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.

Thu, 27 Aug 2026
SL Science (SLBT) swaps ARK for TAAD after going-concern note - Stock Titan

Thu, 27 Aug 2026
SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its Platform - The Manila Times

Thu, 27 Aug 2026
A new FDA filing covers exosomes; studies indicate they can cross the blood-brain barrier - Stock Titan

Tue, 18 Aug 2026
SL Science Holding (SLBT) Stock May Be Fully Priced Even After A 74% Fall - Yahoo Finance

Mon, 17 Aug 2026
SL Science Holding Limited Ordinary Shares (NASDAQ: SLBT) Stock Price, News & Analysis - Kalkine

Sun, 12 Jul 2026
Non-controlling/minority interest of SL Science Holding Limited – NASDAQ:SLBT - TradingView

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	561 (M)
Shares Float	0 (M)
Held by Insiders	59.5 (%)
Held by Institutions	0.2 (%)
Shares Short	107 (K)
Shares Short P.Month	32 (K)

EPS	-0.01
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	1.28
Profit Margin	-72.5 %
Operating Margin	-142.6 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	-7.6 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-0.01
Qtrly Earnings Growth	0 %
Operating Cash Flow	-3 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	-270
PEG Ratio	0
Price to Book value	2.09
Price to Sales	463.01
Price to Cash Flow	-513.24

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.